Although iron deficiency (ID) is considered the most frequent micronutrient deficiency in industrialized countries and is associated with impaired neurodevelopment when occurring in early years, accurate recent estimations of its prevalence are lacking. Our objective was to estimate ID prevalence and associated sociodemographic markers in young children in France. The Saturn-Inf national cross-sectional hospital-based survey recruited 3,831 French children <6 years old between 2008 and 2009 to assess lead poisoning prevalence and to establish a biobank. This secondary analysis measured serum ferritinemia (SF) in sera kept frozen at −80°C for children with sufficient serum aliquots and C-reactive protein <10 mg/L. For the 657 participating children (17% of the Saturn-Inf study), the median age was 3.9 years (interquartile range: 2.2-5.1); 52% were boys. The median SF was 44 μg/L (interquartile range: 28-71). ID prevalence was 2.8% (95% confidence interval Abbreviations: CI, confidence interval; CRP, C-reactive protein; ID, iron deficiency; n, number of observations; SF, serum ferritinemia
| INTRODUCTION
Iron deficiency (ID) is considered the most frequent micronutrient deficiency worldwide, including in industrialized countries (World Health Organization, 2001) . Young children are at high risk of ID because of their volemic mass expansion (Hercberg, Preziosi, & Galan, 2001; Wang, Zhan, Gong, & Lee, 2013; Zimmermann & Hurrell, 2007) . Main ID risk factors in young children are poor perinatal iron stock (e.g., maternal ID and preterm birth), imbalance between requirements and dietary intake (e.g., delayed or inappropriate because of iron-poor diversification), and parental low socioeconomic status (Baker & Greer, 2010; Domellof et al., 2014; Vincelet & Foucault, 2005) . ID is associated with adverse short-and long-term neurological sequelae in juvenile animal models (Beard, 2008) and young humans, as reported in several observational studies and randomized controlled trials (Lozoff, Jimenez, & Wolf, 1991; Moffatt, Longstaffe, Besant, & Dureski, 1994; Roncagliolo, Garrido, Walter, Peirano, & Lozoff, 1998; Wang et al., 2013) .
In this context, ID is a target of various primary preventive strategies supported by medical societies and public health authorities, and some debate exists on the need for universal screening in young children (Baker & Greer, 2010; Domellof et al., 2014; EFSA, 2013; Ghisolfi et al., 2011; Hercberg et al., 2001) . In France, the preventive strategy involves both parents' education oriented toward the consumption of naturally iron-rich foods at food diversification, about 6 months of age, and consumption of iron-fortified food (e.g., follow-on formula;
French ministry of health and welfare, 2005). Iron-fortified follow-on formulas (current mean iron content 0.94 mg/100 ml) have been recommended since the 1980s for all nonbreast-fed infants 6 to 12 months old (French ministry of agriculture, 1978) , and "growingup milk" (mean iron content 1.13 mg/100 ml) has been recommended since the 1990s for all nonbreast-fed child 12 to 36 months old (Ghisolfi et al., 2011) . In other industrialized countries, preventive strategies are based on parental education for adequate food diversification and iron-fortified food as follow-on formulas or cereals in the United States (Centers for Disease Control and Prevention, 1998; EFSA, 2013) or iron supplementation in Denmark (EFSA, 2013) .
The evaluation of the effectiveness of these different strategies should be based on accurate estimations of ID prevalence in the general population and in at-risk subgroups of young children. The US National Health and Nutrition Examination Survey performed between 1999 and 2002 provided general population estimates of ID prevalence based on a random sample of 672 children aged 1 to 3 years, for a mean prevalence of 9% (6.6% to 15.2% depending on ethnic origin and socioeconomic status; Baker & Greer, 2010) . In European countries, ID prevalence in young children has been reported to range from 0% to 41% (all study design types; Bramhagen, Svahn, Hallstrom, & Axelsson, 2011; Cowin, Emond, & Emmett, 2001; Dube, Schwartz, Mueller, Kalhoff, & Kersting, 2010; Dura Trave & Diaz Velaz, 2002; Gompakis et al., 2007; Gunnarsson, Thorsdottir, & Palsson, 2004; Hay, Sandstad, Whitelaw, & Borch-Iohnsen, 2004; Hopkins et al., 2007; Male et al., 2001; McCarthy et al., 2016; Michaelsen, Milman, & Samuelson, 1995; Tabone & Vincelet, 2000; Thane, Walmsley, Bates, Prentice, & Cole, 2000; Thorisdottir, Thorsdottir, & Palsson, 2011; Thorsdottir, Gunnarsson, Atladottir, Michaelsen, & Palsson, 2003; Tuthill et al., 2002; Vendt, Grunberg, Leedo, Tillmann, & Talvik, 2007; Vincelet & Foucault, 2005) or from 4% to 34% (random samples of participants; Cowin et al., 2001; Gompakis et al., 2007; Gunnarsson et al., 2004; Hopkins et al., 2007; McCarthy et al., 2016; Thane et al., 2000; Thorisdottir et al., 2011; Vendt et al., 2007) . In France, the reported prevalence ranges from 33% for infants 10 months old to 40% for infants 16 to 18 months (Tabone & Vincelet, 2000; Vincelet & Foucault, 2005) . Many of these results cannot be used to accurately evaluate the current prevalence of ID in European countries because they predate the implementation of prevention programs (Cowin et al., 2001; Hay et al., 2004; Hopkins et al., 2007; Male et al., 2001; Thane et al., 2000) ; they were exposed to strong selection bias because of single center recruitment (Dura Trave & Diaz Velaz, 2002; Gompakis et al., 2007; Tabone & Vincelet, 2000; Vincelet & Foucault, 
Key messages
• Iron deficiency (ID) prevalence was much lower (3%) in this first cross-sectional national hospital-based study of young children in France than that in other French and European studies performed in underprivileged populations.
• The very low general ID prevalence and the strong associations with social and deprivation indicators we found strongly support prioritizing ID prevention strategies targeting young infants with low socioeconomic status.
• The impact of the French national preventive strategy for ID in children, mainly based on the recommendation of iron-fortified formulas in nonbreast-fed children from age 6 months, should be explored. (Domellof et al., 2014; EFSA, 2013) . Here, we aimed to estimate the ID prevalence in young children <6 years old in France, using for the first time a cross-sectional national hospital-based survey, and to study associated sociodemographic markers. (Table S1 ).
| Participant selection
The Saturn-Inf survey aimed at evaluating lead poisoning in France and was described in detail elsewhere (Etchevers et al., 2014) . In summary, this cross-sectional survey included 3,831 children aged 6 months to 6 years recruited in general pediatrics, pediatric surgery, or pediatric day hospital departments in 143 hospitals in mainland France and French overseas regions between September 2008 and April 2009. A two-stage sampling design was used, the first being a random selection of hospitals, and the second being a selection of all hospitalised children with the following inclusion criteria: any health coverage, blood sampling planned during the hospitalisation, no severe chronical diseases (see detailed list, Lepoutre et al., 2008) , no ongoing iron chelating treatment, and no ongoing diagnosis of lead poisoning. The hospital sampling frame was stratified by region and featured an oversampling of "high-risk areas" of elevated blood lead to increase the precision of estimates of lead poisoning prevalence. The participation rate was 83% for the 273 sampled hospitals and 97% for the 3,949 sampled children.
All the 3,831 included children with the following criteria were eligible for this ancillary study: parents' written consent for secondary analyses, sufficient serum aliquots, lack of inflammatory syndrome defined as C-reactive protein (CRP) <10 mg/L on frozen sera aliquot (because serum ferritinemia [SF] increases with inflammation), and available minimum set of sociodemographic data (i.e., at least age and gender).
| Data collected
At inclusion in the Saturn-Inf survey, the following sociodemographic data were collected by use of a standardized questionnaire during a face-toface interview with pediatricians or nurses: age and sex of the child, country of birth of the mother (migrant or not), region of residence, underprivileged status, and each parent's professional status and educational. The family was considered underprivileged if its health coverage was fully funded by a public grant, which is linked to poverty in France 
| Statistical analysis
We compared the general characteristics of the studied population to those of the Saturn-Inf survey participants excluded from the present ancillary analysis and those of the 2010 French National Perinatal Survey, which is based on a representative sample of births (n = 15418) (Blondel, Lelong, Kermarrec, & Goffinet, 2012) . Taking into account the Saturn-Inf two-stage sampling design (i.e., the cluster effects and the weights linked to the stratification), we described the distribution of SF and studied its crude then adjusted associations with sociodemographic characteristics thanks to the medians' 95% confidence interval (CI) and two multivariable linear regression models (after logarithmic transformation of SF, Bland & Altman, 1996) including variables selected based on a literature review.
The first model included age, gender, and underprivileged status, which we considered as the most representative marker of poor sociodemographic status. The second included all available sociodemographic covariables (except parents' employment because of collinearity). Then, SF was dichotomized with a 10-μg/L threshold to define ID, as suggested in the literature (Baker & Greer, 2010; Dallman, Siimes, & Stekel, 1980; de Montalembert et al., 2012) . The prevalence of ID and its crude association with sociodemographic characteristics were studied by chi-square and Fisher exact tests; no multivariable logistic regression model was used given the low number of ID cases.
All analyses were performed again with a 12-μg/L threshold to define ID, as also suggested in the literature (Baker & Greer, 2010; Cook, Lipschitz, Miles, & Finch, 1974; Dallman et al., 1980; World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level, 2007).
In all analyses, parents' educational level was classified in four categories according to the maximum level obtained: secondary school (including no education, primary school, and general secondary school), professional education (without high school), high school (designating both professional and general education), and higher learning. Parents' professional status was redefined in two categories, employed or not (including housewives, students, and pensioners). Age was used as a continuous variable in multivariable analysis after testing the lack of deviance to linearity; results are presented with age in three categories by periods of variation in iron metabolism and requirements (<2, 2 to less than 3, and ≥3 years old). Regions of residence were categorized (n = 9) by the first level of the nomenclature of territorial units for statistics of the European Union.
All analyses were performed also directly on the population of children selected from Saturn-Inf without applying the two-stage sampling design (results presented in Supporting Information). Missing data were not imputed. The analyses involved use of Stata/SE 13.1 (StataCorp LP Statistics/Data Analysis, Texas 77845, USA).
3 | RESULTS
| Participants
Among the 3,831 children included in the Saturn-Inf study, data for 3,174 (83%) were excluded because of lack of parents' written consent (n = 1), insufficient serum aliquots (n = 2,586, 68%), lack of data on age and/or gender (n = 15, 0.4%), or presence of an inflammatory syndrome (n = 572, 15%, Figure S1 ). The current analysis is based on data for 657 (17%) children.
Considering the two-stage sample design, the mean age of children was 3.7 years (standard error: 0.13; median: 3.9, interquartile range: 2.2-5.1), 52% were boys, 14% had a migrant mother, 47% had an unemployed mother, and 21% a family with an underprivileged status (Tables 1 and S2 (Table 1) .
In a first multivariable linear regression model including age, gender, and underprivileged status, a significantly lower SF was associated with male gender (Table 1) . In a second model including age, gender, mother's country of birth, underprivileged status, parents' educational level, and region of residence, a lower SF was associated with only male gender ( Table 1 ).
Analyses that did not consider the Saturn-Inf sampling design are presented in Table S4 . with an SF threshold of 10 and 12 μg/L, respectively (Tables 1 and S2 ).
With a 10-μg/L threshold, ID was significantly associated with male gender (4%), the mother being a migrant (7%), underprivileged family status (6%), and low maternal educational level (8% vs. 2% for mothers having a secondary school level versus a higher learning level). ID was not associated with age (as a linear variable [no deviance to linearity] or in three categories), parents' professional status or region of residence (Table 1) . ID defined with a 12-μg/L threshold was associated with the same markers as ID defined with a 10-μg/L threshold and also mother's unemployment and low father educational level ( Table S2 ).
Analyses that did not consider the Saturn-Inf sampling design are presented in Tables S4 and S5 Michaelsen et al., 1995; Thorisdottir et al., 2011) . In the four studies that used both SF alone or combined with the same blood sample, ID prevalence was higher with SF used alone versus in a combined marker: 5.8% versus 1.4% (Thorisdottir et al., 2011) , 15.6% versus 7.2% (Male et al., 2001 ), 3.2% versus 2.1% (Dura Trave & Diaz Velaz, 2002) , and 4.6% versus 2.6% (McCarthy et al., 2016) . Thus, our results cannot be explained by using SF as a definition of ID. ID definitions based on SF may also vary depending on the thresholds used and the exclusion of participants with inflammatory status, because SF increases with inflammation (Zimmermann & Hurrell, 2007) . However, among studies evaluating ID prevalence in young children without inflammatory syndrome in industrialized countries, the range of estimations, 1.8% to 20% for SF threshold of 10 μg/L (Baker & Greer, Note. ID = iron deficiency; CI = confidence interval; n = number of observations; OR = odds ratio; SF = serum ferritinemia. Variability in ID prevalence can also be related to differences in population studied, notably participants' age and socioeconomic status. The mean (standard error) age of participants in the present study was 3.7 (0.13) years, which is older than the age in the other published studies involving young children (Baker & Greer, 2010; Bramhagen et al., 2011; Cowin et al., 2001; Dube et al., 2010; Dura Trave & Diaz Velaz, 2002; Gunnarsson, Thorsdottir, Palsson, & Gretarsson, 2007; Hay et al., 2004; Hopkins et al., 2007; Male et al., 2001; McCarthy et al., 2016; Michaelsen et al., 1995; Tabone & Vincelet, 2000; Thorisdottir et al., 2011; Tuthill et al., 2002; Vendt et al., 2007; Vincelet & Foucault, 2005) . However, prevalence did not differ among the age ranges in our study, so age variation cannot explain our results.
Nor could selection bias related to socioeconomic status explain our results. Indeed, with the oversampling strategy of children at risk of lead poisoning, 21% of our population was underprivileged, which is a much higher rate than in the two former French studies on ID deficiency (7%, Foucault, 2005 and 19%, Tabone & Vincelet, 2000) and in the French National Perinatal Survey (13%; Blondel et al., 2012) . This study involved children hospitalized in public general pediatrics units or surgery units which could explain the high rate of underprivileged markers found. If we consider only population-based studies performed in industrialized countries and excluding participants with inflammatory status, reported ID prevalence was higher than in the present study, from 9.2% to 20% (Baker & Greer, 2010; Thane et al., 2000) and 14% to 31% ( The very low prevalence we found as compared to other European studies may be due to national variations in iron intake (Baker & Greer, 2010; EFSA, 2013; Eussen, Alles, Uijterschout, Brus, & van der HorstGraat, 2015) . Indeed, the French ID prevention strategy relies on the recommendation for iron-fortified follow-on formula and growing-up milk for nonbreast-fed children from age 6 to 36 months (Ghisolfi et al., 2011) . In 2005 and 2013, cross-sectional national studies have shown that iron intakes among French infants and toddlers were above the recommended intakes of 7 mg/day until the age of 18 and 24 months old but slightly lower (around 6.5 mg/day) after (Bocquet & Vidailhet, 2015; Fantino & Gourmet, 2008) . In the 2013 study, the consumption of iron-fortified formulas among nonbreast-fed infants and toddlers was gradually declining with age: 89% from 6 to 7 months, 84% from 8 to 11 months, 60% from 12 to 17 months, 57% from 18 to 23 months, 32% from 24 to 29 months, and 24% from 30 to 36 months (Bocquet & Vidailhet, 2015) . The positive effect of follow-on formulas on iron status has been shown in randomized controlled studies (Daly et al., 1996; Fuchs et al., 1993; Gill, Vincent, & Segal, 1997) , with a persistent effect several months after stopping consumption (Daly et al., 1996) . In this study, involving children without chronic disease hospitalized in pediatric medical and surgical departments, we cannot anticipate the direction and the force of a potential selection bias on the usual consumption of iron-fortified formulas compared to nonhospitalized children. Thus, the very low ID prevalence found in this study may be related to adequate iron intakes in young children in France, notably due to the high coverage of follow-on formula.
The socioeconomic markers of ID in children we identified were directly or indirectly related to poor economic or educational level of the family: immigration, underprivileged status, parents' unemployment, and low educational level (Baker & Greer, 2010; Siu, 2015; Tabone & Vincelet, 2000; Vincelet & Foucault, 2005) . These results confirm the statements of expert societies that underlie the need for prevention policies for ID targeting infants and children with inadequate or at risk of inadequate iron status (i.e., low socioeconomic status; Baker & Greer, 2010; Domellof et al., 2014; EFSA, 2013) . We found male gender an independent marker associated with low SF, as in other studies, which also reported its association with elevated of soluble transferrin receptors (a marker of ID) and anemia (Choi, Pai, Im, & Kim, 1999; Domellof et al., 2002; Male et al., 2001; Sherriff, Emond, Hawkins, & Golding, 1999) . Several hypotheses have been raised to explain this association (e.g., greater growth rate than females), but none rely on a robust rationale (Choi et al., 1999; Domellof et al., 2002; Male et al., 2001; Sherriff et al., 1999) .
Our study has several limitations. First, despite a two-stage probability sample design, the initial sample significantly differed from that in the 2010 French National Perinatal survey (Blondel et al., 2012 ; Table S3 ), which may have modified the results of our main outcome, ID prevalence. Second, the attrition rate was almost 83%, mainly because of a factor that is probably independent of ID prevalence in children (insufficient serum aliquots). Third, serum samples were stored for 5 to 6 years at −80°C, conditions that could have modified the SF.
There is no data in the literature about the freezing protocol of SF at this temperature and during this lapse of time. Preliminary results from the birth cohort Generation XXI in Porto, Portugal, in which SF was measured twice in the same aliquot, at the beginning of the survey and after a freezing protocol at −80°C for 3 to 4 years, showed highly preserved values (Barros H, personal communication 2016) .
Reassuring data exist for the stability of CRP after long periods of conservation at −80°C (Nilsson et al., 2005) . The distribution of SF in this study showed several high values despite the exclusion of participants with inflammation (CRP >10 mg/L). Because CRP is an acute-phase inflammation marker, some participants might have been at the end of an inflammatory phase with their CRP already returned to normal and an SF still elevated (Zimmermann & Hurrell, 2007) , which could have decreased the prevalence of ID.
In conclusion, in this first national cross-sectional hospital-based study in France, ID prevalence was much lower (2.8 to 3.2% depending on the SF threshold) than that from other French and European studies of underprivileged populations but close to the low values observed in other population-based studies in Europe. Further studies are needed to explore the relation between this very low ID prevalence and the French national preventive strategy for ID in children that is mainly based on the recommendation of iron-fortified formulas in nonbreast-fed children from age 6 months. The very low general ID prevalence and the strong associations with social and deprivation indicators we found strongly support prioritizing ID prevention strategies targeting young infants with low socioeconomic status.
CONFLICTS OF INTEREST
The funders mentioned in "sources of support" had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. The authors have no patents, products in development, or marketed products to declare.
CONTRIBUTIONS
AB, BB, MC, MdM, LG, PH, SH, CL, ASS, IV, and CV designed and conducted research; HB and YLS provided essential materials; ASS, MC, and YLS performed statistical analysis; ASS and MC wrote the manuscript; ASS and MC have primary responsibility for final content. All authors read, revised critically, and approved the final manuscript.
